Devlin Macgregor is a worldwide leading pharmaceuticals manufacturer, with ISO-17364 rated facilities in five countries. Our new “Humanless Manufacturing Protocol 2023″ (HMP-23) completely removes the need for physically or virtually employed staff in the entire end-to-end pharmaceutical production cycle, enabling us to deliver gold standard, low cost drugs and therapeutics with absolutely zero human oversight or governance
With over 1,000 research scientists and biomedical engineers worldwide, Devlin Macgregor is a leading the fight against chronic and acute diseases with a brand new class of drug therapeutics the utilize our newest Advanced Molecular Delivery Systems (ADMS) which offers 100% treatment efficacy. Gone are the days of potentially harmful “side effects” and needless and costly liability exposure with our newest product formulations
We aren’t just a pharmaceutical manufacturer – Did you know that Devlin Macgregor provides consulting to over 40 of the top 500 organizations? Wasting millions on getting your candidate drug out of Phase IV approval due to obtuse and burdensome regulations or non compliant patients? Our Drug Manufacturing Critical Response Team (DM-CRT) can typically facilitate your Phase IV FDA approval in under 24 hours.
Our Executive Staff Abatement Services (ESAS) and Technology Nullification Team (TNT) can help your organization quickly and discreetly neutralize the risks presented by a competitors executive or board personnel. Our army of experts understands the vulnerabilities you may face from the technology utilized by your competitors. We can expertly nullify these threats to your business, processes, and public reputation.
Devlin Macgregor Board of Directors Vice-Chairman, Doctor Jack Gourdji, took time with his stakeholders to reflect on the less-than acceptable activities as a corporation that have darkened Devlin Macgregor’s reputation in the biosciences, pharmacological research and pharmaceutical manufacturing sectors.
Dr. Gourdji explains the introspective process that the company as a whole has gone through over the greater part of then last decade. Explained, are the multiple actions taken by the board, including funding multiple local Chicago public benefit organizations, as well as establishing the Alphonse Gabriel Capone Scholarship fund for gender-fluid youths in the Greater Chicago and suburban area.
Provasic, the product of a rigorous, seventeen year trial and development process, is a paradigm shifting non-statin, anti-cholesterol and blood lipoprotein harmonizing therapeutic drug. Our newest groundbreaking formulation is unlike all other peer drugs, in that Provasic’s delivery system uniquely alters the iso-nucleotide pathways and N-type calcium channels within the human liver, allowing for a virtual “Metabolic HOV Lane” to be created inside the liver, enabling Provasic to safely, exclusively and fully bypass both the hepatic and renal systems, thereby eliminating the possibility of any and all side effects, and offering true one hundred percent efficacy, a true first in modern medical history.
Groundbreaking pain management therapeutic, offering once-weekly dosage. Two-part, mixable epoxy-based rectal suppository, binds to rectal wall for up to 180 hours. Narcogesic offers up to 1,600% more potency than hydromorphone and 650% greater opioid-receptor affinity than fentanyl. Unique epoxy substrate , when chemically hardened and cured, virtually eliminates potential for narcotic abuse, community diversion and patient-product tampering by facilitating metered doses of painkiller through intestinal mucosa . Narcogesic includes specialized epoxy bio-removal device and refillable silicone injectors. Designed for easy self-use and administration by the patient.
Solarresti is the only prescription mRNA inhibiting titration that provides fortified protection against all currently produced single and two-shot SARS-CoV2 (COVID-19) “Vaccines” by facilitating a protective Lipase-Polytetrafluoroethylene (Lipid-Teflon) barrier on the outer cell membrane of all cells, completely blocking every mRNA delivery system. Topical administration allows for quick and discreet application by adults and children (3 and older) who may face compulsory injection of questionable mRNA based formulations, while simultaneously enabling the fact to be recorded that the injection was apparently deployed successfully. Perfect for healthcare professionals, teachers and active military members.
The 2020 Devlin Macgregor Annual Junket was our most successful in the events 34th anniversary. The conference and team building event was held in Cancun, Mexico at the luxurious Culo de Ratas Resort and Spa. We hosted a record number of guests this year, 134 in total. The VIP and guest list was spectacular this year,
In December 2020, an industrial espionage campaign and concerted effort to sabotage Devlin Macgregor and it’s flagship product Provasic was uncovered. Evidence gathered showed that one or more individuals feigning as Medical staff, illegally entered the Devlin Macgregor research annex at Chicago’s Cook County Hospital to steal blood cytology and liver cell vivisections. The stolen
